President Donald Trump has signed an executive order making some big changes to marijuana policy, the most substantial since 1970. On Dec. 18, Trump ordered the government to stop classifying ...

Medicare drug price negotiations kick-started by the Biden administration will finally result in lower drug prices for seniors beginning Jan. 1. The Medicare-negotiated price cuts will apply to 10 ...

A new digital library based at UC San Diego aims to massively increase the number of drugs that can be easily detected in samples collected from patients, potentially allowing doctors and researchers ...

A version of this story appeared in CNN’s What Matters newsletter. To get it in your inbox, sign up for free here. The Trump administration’s undeclared war on what it calls “narco-terrorists” in ...

TOLEDO, Ohio — Editor's note: The video in the above player was a report from before Dr. Hassan Abbas was charged. This story has been updated to include the arraignment date. A University of Toledo ...

Last month, the U.S. Senate narrowly rejected a bipartisan resolution recently that would have prevented the Trump administration from launching military strikes in Venezuela without congressional ...

The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent. By Rebecca ...

The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy. The price cuts come through the Medicare ...

Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in plain language, emphasizing the impact that economic ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers. Watch the news briefing by ...